Official reiterates faith in HCQ, says use recommended after assessment

The pharmacovigilance programme also monitored the use of HCQ for highrisk healthcare workers in the counrty Prophylaxis refers to treatment given to prevent a disease. YK Gupta, who is also a member of ICMR, said HCQ, an anti-malarial drug, had even less toxicity than chloroquine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gXeLjZ
via IFTTT